KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Quest Diagnostics (DGX) Equity Average: 2009-2025

Historic Equity Average for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to $7.3 billion.

  • Quest Diagnostics' Equity Average rose 7.88% to $7.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $7.3 billion, marking a year-over-year increase of 7.88%. This contributed to the annual value of $6.6 billion for FY2024, which is 7.20% up from last year.
  • Quest Diagnostics' Equity Average amounted to $7.3 billion in Q3 2025, which was up 2.34% from $7.1 billion recorded in Q2 2025.
  • Quest Diagnostics' 5-year Equity Average high stood at $7.3 billion for Q3 2025, and its period low was $6.0 billion during Q1 2023.
  • For the 3-year period, Quest Diagnostics' Equity Average averaged around $6.6 billion, with its median value being $6.6 billion (2024).
  • As far as peak fluctuations go, Quest Diagnostics' Equity Average increased by 19.39% in 2021, and later fell by 6.82% in 2023.
  • Over the past 5 years, Quest Diagnostics' Equity Average (Quarterly) stood at $6.5 billion in 2021, then decreased by 5.52% to $6.1 billion in 2022, then increased by 4.94% to $6.4 billion in 2023, then rose by 6.63% to $6.8 billion in 2024, then climbed by 7.88% to $7.3 billion in 2025.
  • Its Equity Average stands at $7.3 billion for Q3 2025, versus $7.1 billion for Q2 2025 and $6.9 billion for Q1 2025.